Impact of ICCAN on Cancer Treatment Completion and Quality of Life

Participant Inclusion Criteria:

Patient is eligible if he/she is

- fluent in English, Spanish, or Mandarin

- between the ages of 21-80 years old

- cancer patients currently receiving chemotherapy (started within the past month)
and/or radiation therapy (started within the past week), or

- scheduled to begin chemotherapy and/or radiation therapy within the next 2 months
(excluding surgery only patients)

- planning on remaining in the area for at least 1 year

Clinician is eligible if he/she:

- Has an MD or DO degree

- Is the treating physician providing care to a patient enrolled to the study

ICCAN-IO Phase 1: Refinement, participant is eligible if he/she per EMR or self-report:

- Is 18 - 85 years of age

- Has unresectable locally advanced, locally recurrent unresectable, metastatic, or high
risk/early stage TNBC

- Is treated in the NY metropolitan area

- Self-identifies as Black or Hispanic, and/or is low-SES (low SES will be defined as
household income < 200% of federal poverty level)

- Has English or Spanish proficiency

- Agrees to be audio-recorded

ICCAN-IO Phase 2: Pilot RCT, participant is eligible if he/she per EMR or self-report:

- Is 18 - 85 years of age

- Has stage II-III TNBC

- Treated at MSK in Harlem, Nassau, or Manhattan

- Self identifies as Black or Hispanic, and/or is low SES (low SES will be defined as
household income < 200% of federal poverty level)

- Has English or Spanish proficiency

- Agrees to be audio-recorded

ICCAN-IO process evaluation study team participants only:

- Staff member who serves as an Access Facilitator

- Agrees to be audio-recorded

Participant Exclusion Criteria:

Patient is ineligible is he/she is:

- diagnosed with Stage IV disease

- presence of untreated psychiatric disturbance (i.e. acute psychiatric symptoms which
require individual treatment) and/or cognitive impairment disorder (e.g., delirium or
dementia) verified by medical record sufficient to preclude completion of the
assessment measures, interview or informed consent

- has another family member already enrolled in ICCAN (as determined by patient report)

ICCAN-IO Phase 1: Refinement, participant is ineligible if he/she per EMR or self-report:

- Started immunotherapy

- Presence of untreated psychiatric disturbance (i.e. acute psychiatric symptoms which
require individual treatment) and/or cognitive impairment disorder (e.g., delirium or
dementia) sufficient to preclude completion of the assessment measures, interview or
informed consent

- Has another family member already enrolled in ICCAN

- Already participating in or already completed the ICCAN program

ICCAN-IO Phase 2: Pilot RCT, participant is ineligible if he/she per EMR or self-report:

- Started immunotherapy

- Presence of untreated psychiatric disturbance (i.e. acute psychiatric symptoms which
require individual treatment) and/or cognitive impairment disorder (e.g., delirium or
dementia) sufficient to preclude completion of the assessment measures, interview or
informed consent

- Has another family member already enrolled in ICCAN

- Already participating in or already completed the ICCAN program.